Literature DB >> 23913937

A novel algorithm for simplification of complex gene classifiers in cancer.

Raphael A Wilson1, Ling Teng, Karen M Bachmeyer, Mei Lin Z Bissonnette, Aliya N Husain, David M Parham, Timothy J Triche, Michele R Wing, Julie M Gastier-Foster, Frederic G Barr, Douglas S Hawkins, James R Anderson, Stephen X Skapek, Samuel L Volchenboum.   

Abstract

The clinical application of complex molecular classifiers as diagnostic or prognostic tools has been limited by the time and cost needed to apply them to patients. Using an existing 50-gene expression signature known to separate two molecular subtypes of the pediatric cancer rhabdomyosarcoma, we show that an exhaustive iterative search algorithm can distill this complex classifier down to two or three features with equal discrimination. We validated the two-gene signatures using three separate and distinct datasets, including one that uses degraded RNA extracted from formalin-fixed, paraffin-embedded material. Finally, to show the generalizability of our algorithm, we applied it to a lung cancer dataset to find minimal gene signatures that can distinguish survival. Our approach can easily be generalized and coupled to existing technical platforms to facilitate the discovery of simplified signatures that are ready for routine clinical use. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23913937      PMCID: PMC4233649          DOI: 10.1158/0008-5472.CAN-13-0324

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  Direct multiplexed measurement of gene expression with color-coded probe pairs.

Authors:  Gary K Geiss; Roger E Bumgarner; Brian Birditt; Timothy Dahl; Naeem Dowidar; Dwayne L Dunaway; H Perry Fell; Sean Ferree; Renee D George; Tammy Grogan; Jeffrey J James; Malini Maysuria; Jeffrey D Mitton; Paola Oliveri; Jennifer L Osborn; Tao Peng; Amber L Ratcliffe; Philippa J Webster; Eric H Davidson; Leroy Hood; Krassen Dimitrov
Journal:  Nat Biotechnol       Date:  2008-02-17       Impact factor: 54.908

2.  Identification of a PAX-FKHR gene expression signature that defines molecular classes and determines the prognosis of alveolar rhabdomyosarcomas.

Authors:  Elai Davicioni; Friedrich Graf Finckenstein; Violette Shahbazian; Jonathan D Buckley; Timothy J Triche; Michael J Anderson
Journal:  Cancer Res       Date:  2006-07-15       Impact factor: 12.701

3.  Gene expression profiling for survival prediction in pediatric rhabdomyosarcomas: a report from the children's oncology group.

Authors:  Elai Davicioni; James R Anderson; Jonathan D Buckley; William H Meyer; Timothy J Triche
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

4.  Molecular classification of rhabdomyosarcoma--genotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group.

Authors:  Elai Davicioni; Michael J Anderson; Friedrich Graf Finckenstein; James C Lynch; Stephen J Qualman; Hiroyuki Shimada; Deborah E Schofield; Jonathan D Buckley; William H Meyer; Poul H B Sorensen; Timothy J Triche
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

5.  Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family.

Authors:  Janos Sumegi; Renae Streblow; Robert W Frayer; Paola Dal Cin; Andrew Rosenberg; Aurelia Meloni-Ehrig; Julia A Bridge
Journal:  Genes Chromosomes Cancer       Date:  2010-03       Impact factor: 5.006

6.  Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry.

Authors:  Marco Wachtel; Tina Runge; Ivo Leuschner; Sabine Stegmaier; Ewa Koscielniak; Jörn Treuner; Bernhard Odermatt; Silvia Behnke; Felix K Niggli; Beat W Schäfer
Journal:  J Clin Oncol       Date:  2006-01-03       Impact factor: 44.544

7.  Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.

Authors:  Marco Wachtel; Marcel Dettling; Eva Koscielniak; Sabine Stegmaier; Jörn Treuner; Katja Simon-Klingenstein; Peter Bühlmann; Felix K Niggli; Beat W Schäfer
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

8.  Diffuse myogenin expression by immunohistochemistry is an independent marker of poor survival in pediatric rhabdomyosarcoma: a tissue microarray study of 71 primary tumors including correlation with molecular phenotype.

Authors:  Amy Heerema-McKenney; Liliane C D Wijnaendts; Joseph F Pulliam; Dolores Lopez-Terrada; Jesse K McKenney; Shirley Zhu; Kelli Montgomery; Janet Mitchell; Robert J Marinelli; Augustinus A M Hart; Matt van de Rijn; Sabine C Linn
Journal:  Am J Surg Pathol       Date:  2008-10       Impact factor: 6.394

9.  Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups.

Authors:  Odile Oberlin; Annie Rey; Elizabeth Lyden; Gianni Bisogno; Michael C G Stevens; William H Meyer; Modesto Carli; James R Anderson
Journal:  J Clin Oncol       Date:  2008-05-10       Impact factor: 44.544

10.  Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.

Authors:  Kerby Shedden; Jeremy M G Taylor; Steven A Enkemann; Ming-Sound Tsao; Timothy J Yeatman; William L Gerald; Steven Eschrich; Igor Jurisica; Thomas J Giordano; David E Misek; Andrew C Chang; Chang Qi Zhu; Daniel Strumpf; Samir Hanash; Frances A Shepherd; Keyue Ding; Lesley Seymour; Katsuhiko Naoki; Nathan Pennell; Barbara Weir; Roel Verhaak; Christine Ladd-Acosta; Todd Golub; Michael Gruidl; Anupama Sharma; Janos Szoke; Maureen Zakowski; Valerie Rusch; Mark Kris; Agnes Viale; Noriko Motoi; William Travis; Barbara Conley; Venkatraman E Seshan; Matthew Meyerson; Rork Kuick; Kevin K Dobbin; Tracy Lively; James W Jacobson; David G Beer
Journal:  Nat Med       Date:  2008-07-20       Impact factor: 53.440

View more
  3 in total

1.  Clinical Application of Prognostic Gene Expression Signature in Fusion Gene-Negative Rhabdomyosarcoma: A Report from the Children's Oncology Group.

Authors:  Pooja Hingorani; Edoardo Missiaglia; Janet Shipley; James R Anderson; Timothy J Triche; Mauro Delorenzi; Julie Gastier-Foster; Michele Wing; Douglas S Hawkins; Stephen X Skapek
Journal:  Clin Cancer Res       Date:  2015-10-15       Impact factor: 12.531

Review 2.  Molecular diagnostics in the management of rhabdomyosarcoma.

Authors:  Michael A Arnold; Fredric G Barr
Journal:  Expert Rev Mol Diagn       Date:  2017-01-06       Impact factor: 5.225

3.  Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group.

Authors:  Samuel L Volchenboum; Jorge Andrade; Lei Huang; Donald A Barkauskas; Mark Krailo; Richard B Womer; Andreas Ranft; Jenny Potratz; Uta Dirksen; Timothy J Triche; Elizabeth R Lawlor
Journal:  J Pathol Clin Res       Date:  2015-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.